Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target named "pseudogene similar to part of ribonucleotide reductase M2 polypeptide" (ENSG00000224630) is classified as a pseudogene, meaning it is a segment of DNA that resembles the functional RRM2 gene but does not encode an active or functional protein product[1][4]. The RRM2 gene itself encodes an essential subunit of ribonucleotide reductase, which is a crucial enzyme for deoxyribonucleotide synthesis and DNA replication in humans[2][3], but pseudogenes like ENSG00000224630 typically do not contribute to protein expression or biological activity. They may impact gene regulation or genome stability in rare cases, but no specific function or disease association is documented for this pseudogene[1]. Summary: ENSG00000224630 is a non-coding pseudogene, not a therapeutic target, lacking known molecular, biological, or clinical relevance. If structured target annotation is needed, most fields should be returned as null or incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribonucleotide reductase M2 polypeptide.